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 CURRENTOPINION Living-donor liver transplantation: why the Sun
rises in the East and sets in the West?
Henrik Petrowskya, Ki-Hun Kimb, and Yaman Tokatc
The current section of liver transplantation focuses
on hot topics in living-donor liver transplantation
(LDLT). LDLT is worldwide practiced, but the highest
experience is currently at home in the Eastern hemi-
sphere. Themain aim of this sectionwas to highlight
important aspects of LDLT including high-end
surgical techniques andchallenging indications.Cur-
rent Opinion in Organ Transplantation is pleased to
present five top reviews fromrenowned international
experts from Eastern andWestern centres, including
groups from India [1], Turkey [2], South Korea [2],
Hong-Kong [3], Canada [4] and Germany [5].
There is no doubt that the success of LDLT is
highly depending on the technical performance of
the procedure. A comprehensive review from Asan
Medical Center in Seoul, South Korea, defined four
key elements of technical success of LDLT, namely
adequate graft volume, sufficient inflow, good out-
flow and secure bile duct anastomosis [6]. This
definition of technical success is based on the
unique experience of one of the worldwide high-
est-performance centres in LDLT celebrating the
extraordinary achievement of 5000 LDLTs in 2018
[7]. Therefore, two reviews of this section have been
designated to important technical aspects of biliary
[1] and hepatic artery reconstruction [2] in LDLT.
Biliary reconstruction is often considered as
Achilles heel of liver transplantation [8]. The current
state of high-end range of biliary reconstruction in
LDLT has been reported in this section by experts
from The Medanta Institute in Delhi, India [1]. The
authors highlight the importance of modern mag-
netic resonance-based biliary imaging modalities in
living donors in order to study the individual anat-
omy of the biliary tree and to be best prepared for
donor and recipient surgery. The overall benefit of
improved biliary imaging translates in the best pos-
sible selection of potential living donors as well as
avoidance of biliary complications in donors and
recipients. Furthermore, the review focuses on
important technical details such as various types
of biliary reconstruction and the question whether
anastomotic stenting should be performed.
Hepatic artery reconstruction in LDLT is one of
the most important technical parts, which needs the
highest attention and perfection to avoid potential
complications including graft loss. Hepatic artery
reconstruction in LDLT is often more demanding
and requires a high microsurgical skill set compared
with deceased donor liver transplantation (DDLT).
The main reason behind these facts is related to the
shorter length andmuch smaller diameters of arterial
segments of the partial graft. In this section, the
comprehensive joined review of renowned experts
from Turkey and South Korea focused on important
anatomical and technical details of arterial revascular-
ization in LDLT [2]. The authors defined three impor-
tant key factors for successful hepatic artery
reconstructionsuchas theselectionof recipientartery,
the quality and length of the graft artery, and the
anastomotic technique. There is an ongoing debate
whether arterial reconstruction in LDLT should be
performed under the microscope or with loops.
Although the review cannot resolve this debate, the
authors advocate for using the microscope and high-
light the advantages of this important tool.
MELD score and hepatocellular carcinoma
(HCC) present the two most important factors,
which currently have the greatest impact on listing
and organ allocation in DDLT worldwide. Many
believe that LDLT should be primarily reserved for
candidates with low MELD scores or HCC. Whether
patients with high MELD scores (35þ) should also
have access to LDLT is discussed by expert authors
from Hong Kong having a long tradition in LDLT
[3]. Various studies on LDLT in high MELD candi-
dates define high MELD by cut-off scores of 25. It is
important to emphasize that high MELD should be
considered when MELD scores are 35 or greater. The
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authors state that the main argument against LDLT
in high-acuity patients relates to the concern that
partial grafts might not provide the necessary phys-
iological function to sustain the high demands
required in critically ill recipients while simulta-
neously exposing a healthy donor to risk. The review
highlights the importance of timely transplant,
the impacts of partial graft and donor morbidity
in high MELD (35þ) candidates undergoing LDLT.
Although the authors give recommendations when
LDLT should not be performed in high MELD
patients, they clearly support the concept of LDLT
in this sick population in high-volume centres with
profound experience.
Because the literature of liver transplantation for
HCC is rapidly evolving, we have chosen one review
exploring the status of LDLT for HCC [5]. This article
is authored by leading experts from theUniversity of
Toronto, Canada, who are internationally known
for their work in this field [9]. The structure of the
article follows the discussion of recipient, tumour,
donor and ethical factors, which need to be thor-
oughly considered when LDLT is evaluated in
patients withHCC. They speculate on incorporating
new technologies, response to treatment and deter-
mination of tumour behaviour into HCC criteria for
liver transplantation what is just beyond the near
horizon. Overall, this article demonstrates the great
advantages of LDLT for HCC in the light of contin-
uous organ shortage of deceased donors.
Another hot topic in LDLT extends to the new
indication of treating unresectable colorectal liver
metastases (CRLMs) by liver transplantation. The
main credit of exploring this challenging tumour
indication goes to the liver transplant unit fromOslo,
Norway [10]. This group introduced a novel proce-
dure combining partial liver transplantation from
split grafts with elements of two-stage hepatectomy
for unresectable CRLM [11], also named as RAPID
concept (Resection And Partial Liver segment 2-3-
transplantation with Delayed total hepatectomy).
The same concept when applied to LDLT has been
first performed by a German transplant group who
authored the last article in this section [5]. This
technical article is accompanied by nice illustrations
presenting the principle of this complex procedure.
Although LDLT was pioneered and initially pro-
moted in the western hemisphere, many Asian LDLT
programmes nowadays outperform western centres
apart from some exceptions. Although western coun-
tries have primarily promoted deceased donor resour-
ces to expand the organ pool for liver transplantation,
Asian countries have prioritized LDLT as the best
approach to cope with cultural, religious and epidemic
issue in their countries neglecting the great potential of
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FIGURE 1. Total number of performed living-donor and deceased donor liver transplantations in the year 2017. Numbers are
presented for Eastern (left side) and Western countries as well as the Eurotransplant region (right side), which includes Austria, Belgium,
Croatia, Germany, Hungary, Luxembourg and Slovenia. Data for Taiwan, South Korea, Turkey, Italy, Spain, France, UK, Canada and
the United States were retrieved from the International Registry in Organ Donation and Transplantation (www.irodat.org), data for India
and Japan from the Global Observatory on Donation and Transplantation database (www.transplant-observatory.org), and data for the
Eurotransplant region from the annual reports of Eurotransplant (www.eurotransplant.org).
Living-donor liver transplantation Petrowsky et al.
1087-2418 Copyright  2019 Wolters Kluwer Health, Inc. All rights reserved. www.co-transplantation.com 621
 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.
perspective article authored by LDLT experts of a high-
volume centre in Taiwan highlighted the issues why
LDLT became so successful in many Asian countries
[12]. The authors concluded that ‘LDLT flourishes in
Asiaas a response towhat isdictatedas thenorminAsia
societies regarding religion, culture, tradition and poli-
tics, aswell as the severe organ shortage in apopulation
with the highest demand for liver transplantation due
to its endemicity with HBV and HCV-related disease
and high incidence of HCC’ [12]. However, we have to
keep in mind that the primary mission of both LDLT
andDDLT is to save lives andpreventdropout aswell as
death on the waiting list. Under this perspective, the
East needs to further develop deceased donation,while
theWest requires reviving living donation, just for the
simple reason of saving lives (Fig. 1). As long as organ
shortage will remain, LDLT offers a great treatment for
many indications especiallywhen timeplays an impor-
tant role tohaveaccess toa life-savingorgan.Therefore,
manywill agree that the sunof LDLTwill remain to rise
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